Mesenchymal stem cell and islet co-transplantation promotes graft revascularization and function

Transplantation

Volumn 89, Issue 12, 2010, Pages 1438-1445

  Ito, Taihei ^a   Itakura, Shin ^a   Todorov, Ivan ^a   Rawson, Jeffrey ^a   Asari, Sadaki ^a   Shintaku, Jonathan ^a   Nair, Indu ^a   Ferreri, Kevin ^a   Kandeel, Fouad ^a   Mullen, Yoko ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Islet graft revascularization; Islet transplantation; Mesenchymal stem cell

Indexed keywords

VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GRAFT RECIPIENT; INTRAVENOUS GLUCOSE TOLERANCE TEST; KIDNEY CAPSULE; LEWIS RAT; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RAT; REVASCULARIZATION; SCID MOUSE; STREPTOZOCIN DIABETES;

ANIMALS; CELL SEPARATION; FLOW CYTOMETRY; GLUCOSE TOLERANCE TEST; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, SCID; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, INBRED LEW; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VON WILLEBRAND FACTOR;

EID: 77954084921     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181db09c4     Document Type: Article

References (33)

1. Davalli AM, Ogawa Y, Ricordi C, et al. A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice. Transplantation 1995; 59: 817.
2. Jirak D, Kriz J, Strzelecki M, et al. Monitoring the survival of islet transplants by MRI using a novel technique for their automated detection and quantification. MAGMA 2009; 22: 257.
3. Korsgren O, Lundgren T, Felldin M, et al. Optimising islet engraftment is critical for successful clinical islet transplantation. Diabetologia 2008; 51: 227.
4. Ryan EA, Lakey JR, Rajotte RV, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001; 50: 710.
5. Henderson JR, Moss MC. A morphometric study of the endocrine and exocrine capillaries of the pancreas. Q J Exp Physiol 1985; 70: 347.
6. Kuroda M, Oka T, Oka Y, et al. Colocalization of vascular endothelial growth factor (vascular permeability factor) and insulin in pancreatic islet cells. J Clin Endocrinol Metab 1995; 80: 3196.
7. Lifson N, Lassa CV, Dixit PK. Relation between blood flow and morphology in islet organ of rat pancreas. Am J Physiol 1985; 249 (1 pt 1): E43.
8. Bearer EL, Orci L. Endothelial fenestral diaphragms: A quick-freeze, deep-etch study. J Cell Biol 1985; 100: 418.
9. Carlsson PO, Liss P, Andersson A, et al. Measurements of oxygen tension in native and transplanted rat pancreatic islets. Diabetes 1998; 47: 1027.
10. Brissova M, Shostak A, Shiota M, et al. Pancreatic islet production of vascular endothelial growth factor-a is essential for islet vascularization, revascularization, and function. Diabetes 2006; 55: 2974.
11. Jansson L, Carlsson PO. Graft vascular function after transplantation of pancreatic islets. Diabetologia 2002; 45: 749.
12. Carlsson PO, Andersson A, Carlsson C, et al. Engraftment and growth of transplanted pancreatic islets. Ups J Med Sci 2000; 105: 107.
13. Vajkoczy P, Olofsson AM, Lehr HA, et al. Histogenesis and ultrastruc-ture of pancreatic islet graft microvasculature. Evidence for graft revas-cularization by endothelial cells of host origin. Am J Pathol 1995; 146: 1397.
14. Menger MD, Jaeger S, Walter P, et al. Angiogenesis and hemodynamics of microvasculature of transplanted islets of Langerhans. Diabetes 1989; 38(suppl 1): 199.
15. Brissova M, Fowler M, Wiebe P, et al. Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets. Diabetes 2004; 53: 1318.
16. Carlsson PO, Mattsson G. Oxygen tension and blood flowinrelation to revascularization in transplanted adult and fetal rat pancreatic islets. Cell Transplant 2002; 11: 813.
17. Mattsson G, Carlsson PO, Olausson K, et al. Histological markers for endothelial cells in endogenous and transplanted rodent pancreatic islets. Pancreatology 2002; 2: 155.
18. Brissova M, Powers AC. Revascularization of transplanted islets: Can it be improved? Diabetes 2008; 57: 2269.
19. Martens TP, See F, Schuster MD, et al. Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium. Nat Clin Pract Cardiovasc Med 2006; 3(suppl 1): S18.
20. Oswald J, Boxberger S, Jorgensen B, et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 2004; 22: 377.
21. Silva GV, Litovsky S, Assad JA, et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 2005; 111: 150.
22. Shake JG, Gruber PJ, Baumgartner WA, et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: Engraftment and functional effects. Ann Thorac Surg 2002; 73: 1919.
23. Itakura S, Asari S, Rawson J, et al. Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat. Am J Transplant 2007; 7: 336.
24. Ding Y, Xu D, Feng G, et al. Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and-9. Diabetes 2009; 58: 1797.
25. Johansson U, Rasmusson I, Niclou SP, et al. Formation of composite endothelial cell-mesenchymal stem cell islets: Anovel approach to promote islet revascularization. Diabetes 2008; 57: 2393.
26. Solari MG, Srinivasan S, Boumaza I, et al. Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia. J Autoimmun 2009; 32: 116.
27. Cross SE, Richards SK, Clark A, et al. Vascular endothelial growth factor as a survival factor for human islets: Effect of immunosuppressive drugs. Diabetologia 2007; 50: 1423.
28. Ball SG, Shuttleworth CA, Kielty CM. Mesenchymal stem cells and neovascularization: Role of platelet-derived growth factor receptors. J Cell Mol Med 2007; 11: 1012.
29. Toma C, Pittenger MF, Cahill KS, et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002; 105: 93.
30. Johansson U, Elgue G, Nilsson B, et al. Composite islet-endothelial cell grafts: A novel approach to counteract innate immunity in islet transplantation. Am J Transplant 2005; 5: 2632.
31. Ghajar CM, Blevins KS, Hughes CC, et al. Mesenchymal stem cells enhance angiogenesisin mechanically viable prevascularized tissues via early matrix metalloproteinase upregulation.Tissue Eng 2006; 12: 2875.
32. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007; 110: 3499.
33. Riekstina U, Carkstina I, Parfejevs V, et al. Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis. Stem Cell Rev 2009; 5: 378.